Company research
Modular Medical, Inc.
CIK 1074871Updated Sep 24, 2026
SecurityMODD · NASDAQ · equity
Name history
BEAR LAKE RECREATION INC · through May 25, 2017
MODD price & chart
Loading TradingView…
NASDAQ:MODD on TradingView ↗About the company
We are a pre-revenue medical device company focused on the design, development and commercialization of innovative insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. Through the creation of a novel two part patch pump, we seek to fundamentally alter the trade-offs between cost and complexity and access to the higher standards of care that presently-available insulin pumps provide. By simplifying and streamlining the user experience from introduction, prescription, reimbursement, training and day-to-day use, we seek to expand the wearable insulin delivery device market beyond the highly motivated “super users” and expand the category into the mass market. The product seeks to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets. In January 2024, we submitted a 510(k) premarket notification to the United States Food and Drug Administration (the “FDA”) for our initial product, our MODD1, and, in September 2024, we received FDA clearance to market and sell our MODD1 pump in the United States. In August 2025, we announced the first human use of our MODD1 pump delivering insulin to a h…
In the news
No coverage from other publishers is available.
Recent filings
Shareholder Director Nominations
Items 5.08
EFFECT filing
10-Q filing
SCHEDULE 13G/A filing
SCHEDULE 13G filing
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 14,832,000Source | 18,735,000Source | 13,807,000Source | 7,245,248Source |
| Property, Plant and Equipment, NetUSD | 6,866,000Source | 4,453,000Source | 2,975,000Source | 1,721,311Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,942,000Source | 13,095,000Source | 9,232,000Source | 3,799,324Source |
| Assets, CurrentUSD | 7,542,000Source | 13,517,000Source | 9,697,000Source | 4,046,190Source |
| Prepaid Expense and Other Assets, CurrentUSD | 600,000Source | 422,000Source | 465,000Source | 146,866Source |
| Operating Lease, Right-of-Use AssetUSD | 363,000Source | 765,000Source | 1,135,000Source | 1,477,747Source |
| Other Assets, NoncurrentUSD | 61,000Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,873,000Source | 1,658,000Source | 2,272,000Source | 2,169,272Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 5,000Source | 54,000Source | 32,000Source | 10,949Source |
| Additional Paid in CapitalUSD | 125,949,000Source | 101,776,000Source | 77,432,000Source | 53,523,734Source |
| Retained Earnings (Accumulated Deficit)USD | -112,995,000Source | -84,753,000Source | -65,929,000Source | -48,458,707Source |
| Stockholders' Equity Attributable to ParentUSD | 12,959,000Source | 17,077,000Source | 11,535,000Source | 5,075,976Source |
| Liabilities and EquityUSD | 14,832,000Source | 18,735,000Source | 13,807,000Source | 7,245,248Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,873,000Source | 1,265,000Source | 1,455,000Source | 979,305Source |
| Operating Lease, Liability, CurrentUSD | 393,000Source | 423,000Source | 373,000Source | 355,224Source |
| Accounts Payable, CurrentUSD | 992,000Source | 338,000Source | 802,000Source | 285,383Source |
| Operating Lease, Liability, NoncurrentUSD | — | 393,000Source | 817,000Source | 1,189,967Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 488,000Source | 504,000Source | 280,000Source | 338,698Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,778,000Source | 2,381,000Source | 2,701,000Source | 2,724,048Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | -4,387,000Source | -4,400,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -23,753,000Source | -15,720,000Source | -13,952,000Source | -11,011,644Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -3,932,000Source | -2,493,000Source | -1,700,000Source | -1,637,751Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,932,000Source | 2,493,000Source | 1,700,000Source | 1,637,751Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 21,532,000Source | 22,076,000Source | 21,085,000Source | 7,372,347Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -5,277,048Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 6,942,000Source | 13,095,000Source | 9,232,000Source | 3,799,324Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 30,000Source | — | — | — |
| Income Taxes Paid, NetUSD | 2,000Source | 2,000Source | 2,000Source | 1,600Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 37,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | -21,000Source | — |
| General and Administrative ExpenseUSD | 7,587,000Source | 4,351,000Source | 4,649,000Source | 4,816,567Source |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | 1,600Source |
| Net Income (Loss) Attributable to ParentUSD | -28,242,000Source | -18,824,000Source | -17,470,000Source | -13,878,936Source |
| Operating ExpensesUSD | 27,560,000Source | 19,048,000Source | 17,529,000Source | 13,878,311Source |
| Proceeds from Issuance of Common StockUSD | 15,673,000Source | 2,114,000Source | 278,000Source | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -27,560,000Source | -19,048,000Source | -17,529,000Source | -13,878,311Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -28,240,000Source | -18,822,000Source | -17,468,000Source | -13,877,336Source |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | 1,600Source |
| Net Income (Loss) Attributable to ParentUSD | -28,242,000Source | -18,824,000Source | -17,470,000Source | -13,878,936Source |
| Earnings Per Share, BasicUSD per share | -12.36Source | -0.51Source | -0.78Source | -1.28Source |
| Earnings Per Share, DilutedUSD per share | -12.36Source | -0.51Source | -0.78Source | -1.28Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,285,000Source | 37,007,000Source | 22,377,000Source | 10,880,527Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,285,000Source | 37,007,000Source | 22,377,000Source | 10,880,527Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | 1,600Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,672,000Source | 1,063,000Source | 426,000Source | 152,399Source |
| General and Administrative ExpenseUSD | 7,587,000Source | 4,351,000Source | 4,649,000Source | 4,816,567Source |
| Operating ExpensesUSD | 27,560,000Source | 19,048,000Source | 17,529,000Source | 13,878,311Source |
| Other ExpensesUSD | 100,000,000Source | — | 75,000Source | — |
| Other IncomeUSD | 155,000Source | 226,000Source | 61,000Source | 975Source |
| Research and Development ExpenseUSD | 19,973,000Source | 14,697,000Source | 12,880,000Source | 9,061,744Source |
Offerings
Registration 333-293842
- Gross proceeds
- 11992867.6
- Net proceeds
- 11153366.87
- Deal price
- 0.1762
- Shares
- 68063948
- Offering price
- $0.176200
- Ticker
- MODD
Filing attachments
ea028710801ex99-1.htm · 8-K · 2026-04-21
EX-99.1 4 ea028710801ex99-1.htm PRESS RELEASE DATED APRIL 19, 2026 Exhibit 99.1 Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. (“Modular Medical” or the “Company”) (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the “Offering”) consisting of 750,000 shares of the Company’s common stock at…
Read attachment ↗ea028661101ex99-1.htm · 8-K · 2026-04-16
EX-99.1 2 ea028661101ex99-1.htm PRESS RELEASE BY MODULAR MEDICAL, INC. DATED APRIL 16, 2026 Exhibit 99.1 Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement SAN DIEGO, CA / ACCESSWIRE / April 16, 2026 / Modular Medical, Inc. (“Modular Medical” or the “Company”) (NASDAQ: MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained …
Read attachment ↗ea028392901ex99-1.htm · 8-K · 2026-03-31
EX-99.1 3 ea028392901ex99-1.htm PRESS RELEASE BY MODULAR MEDICAL, INC. DATED MARCH 26, 2026 Exhibit 99.1 Modular Medical Announces 1-for-30 Reverse Stock Split SAN DIEGO, CA / ACCESSWIRE / March 26, 2026 / Modular Medical, Inc. (“Modular Medical” or the “Company”) (NASDAQ: MODD), an innovative insulin delivery technology company, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split will become effective at 5:30am ET on …
Read attachment ↗ea028038801ex99-1.htm · 8-K · 2026-03-06
EX-99.1 3 ea028038801ex99-1.htm PRESS RELEASE DATED MARCH 3, 2026 Exhibit 99.1 Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) (“Modular Medical” or the “Company”), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult “almost-pumpers” with its user-friendly and affordable design, today announced the pri…
Read attachment ↗ea027136801ex99-1_modular.htm · 8-K · 2025-12-31
EX-99.1 2 ea027136801ex99-1_modular.htm PRESS RELEASE OF MODULAR MEDICAL, INC. DATED DECEMBER 31, 2025 Exhibit 99.1 Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule SAN DIEGO, Calif., December 31, 2025 - Modular Medical, Inc. (NASDAQ: MODD) (“Modular Medical” or the “Company”), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and af…
Read attachment ↗ea026926401ex4-1_modular.htm · 8-K · 2025-12-11
EX-4.1 3 ea026926401ex4-1_modular.htm FORM OF WARRANT Exhibit 4.1 COMMON STOCK PURCHASE WARRANT MODULAR MEDICAL, inc. Warrant Shares: _______ Initial Issue Date: _________, 2025 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after __________________ (the “Initial Exerci…
Read attachment ↗